Buy & Sell Quest Diagnostics Inc (DGX) – Quest Diagnostics Inc Price Today
Aura AI Summary
Key Stats
- $20.66BMarket Cap
- HealthSector
- -11.94%3M Drawdown
- $26.67BEnterprise Value
- 1.84%Dividend Yield
- 69 daysTypical Hold Time
Quest Diagnostics Inc (DGX) is currently valued at a market capitalization of $20.66B, with an enterprise value of $26.67B. Over the past 52 weeks, Quest Diagnostics Inc has traded between a low of $166.42 and a high of $211.91, highlighting its annual price range. Over the past three months, Quest Diagnostics Inc has recorded a drawdown of -11.94%, reflecting recent price volatility. Quest Diagnostics Inc offers a dividend yield of 1.84%, with the most recent dividend of $0.86 paid on 06 Apr 26. On average, investors hold Quest Diagnostics Inc for approximately 69 days, indicating typical investor behavior on the platform.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Most Recent News
Inflation rise and US-China trade talks spark volatility in Treasury yields, gold, silver, and stocks.
Recent inflation data shows accelerating price pressures, especially from energy costs, keeping the Federal Reserve cautious and supporting higher Treasury yields and a strong US dollar. The Trump-Xi meeting improved market sentiment but lacked confi...
Bill C-22 sparks global tech backlash over risks to Canada's digital economy and privacy.
Canada's proposed Bill C-22 faces strong opposition from major tech firms like Meta, Apple, and Signal, as well as VPN providers, due to concerns it could force companies to weaken encryption and compromise digital privacy. Industry leaders warn this...
Bill C-22 risks harming Quebec's tech economy by driving away investments and data centers.
Bill C-22 in Canada faces strong opposition from tech leaders and experts who warn it threatens the digital economy by undermining data privacy and encryption. Quebec's tech sector, especially in AI and cloud infrastructure, could lose investments, t...